The purpose of this article is to investigate the clinical significance and safety of HPV vaccine. This paper also describes the effects of hpv vaccine in men as well as in women. The cost of diseases caused by HPV is a significant burden. Therefore, HPV vaccination is currently being implemented in more than 80 countries as part of the National Immunization Program (NIP). Recently, A 9-valent vaccine was added to prevent the disease of HPV 31, 33, 45, 52 and 58. In terms of safety, the side effects profile was similar to the 9-valent vaccine and the 4-valent vaccine. Consequently, The HPV vaccine can relieve burden for cervical cancer and HPV-related diseases.
목차
Abstract 서론 본론 HPV로 인해 발병하는 질병에 따른 부담(burden) 기존 HPV 백신 대비 9가백신의 효과 효능(efficacy) 면역원성(Immunogenicity) 남성에서의 HPV 백신 효능 HPV 백신의 안전성 고찰 및 결론 참고문헌
한국보건사회약료경영학회 [Korean Academy of Social & Managed Care Phemacy]
설립연도
2009
분야
의약학>약학
소개
본 학회는 비영리 학술단체로서 환자의 삶의 질 향상을 위한 약료(pharmaceutical care)가 보장될 수 있도록 약료경영약학(managed care pharmacy)을 발전시키는 데 궁극 목적을 두고 다음과 같은 활동을 전개하여 사회에 기여하며 회원 상호간의 친목을 도모한다.
간행물
간행물명
한국보건사회약료경영학회지 [Journal of Korean Academy of Managed Care Pharmacy]